PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-69.69%
Both yoy net incomes decline, with VET at -84.18%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-9.04%
Negative yoy D&A while VET is 0.69%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-89.07%
Negative yoy deferred tax while VET stands at 575.43%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
304.02%
Slight usage while VET is negative at -39.07%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
304.02%
Some yoy usage while VET is negative at -39.07%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
60.80%
Lower 'other non-cash' growth vs. VET's 461.50%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-33.19%
Both yoy CFO lines are negative, with VET at -15.02%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
23.56%
Some CapEx rise while VET is negative at -111.01%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.86%
Growth well above VET's 75.10%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
28.76%
We have mild expansions while VET is negative at -97.56%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.